OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
PRC2-Mediated Epigenetic Suppression of Type I IFN-STAT2 Signaling Impairs Antitumor Immunity in Luminal Breast Cancer
Juyeong Hong, Ji Hoon Lee, Zhao Zhang, et al.
Cancer Research (2022) Vol. 82, Iss. 24, pp. 4624-4640
Open Access | Times Cited: 13
Juyeong Hong, Ji Hoon Lee, Zhao Zhang, et al.
Cancer Research (2022) Vol. 82, Iss. 24, pp. 4624-4640
Open Access | Times Cited: 13
Showing 13 citing articles:
Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer
Xue Chen, Qinfan Yao, Xinyu Gu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 202
Xue Chen, Qinfan Yao, Xinyu Gu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 202
The hallmarks of cancer immune evasion
Claudia Galassi, Timothy A. Chan, Ilio Vitale, et al.
Cancer Cell (2024) Vol. 42, Iss. 11, pp. 1825-1863
Closed Access | Times Cited: 57
Claudia Galassi, Timothy A. Chan, Ilio Vitale, et al.
Cancer Cell (2024) Vol. 42, Iss. 11, pp. 1825-1863
Closed Access | Times Cited: 57
Obesity-associated epigenetic alterations and the obesity-breast cancer axis
C Lagarde, Joachim Kavalakatt, Megan C. Benz, et al.
Oncogene (2024) Vol. 43, Iss. 11, pp. 763-775
Closed Access | Times Cited: 5
C Lagarde, Joachim Kavalakatt, Megan C. Benz, et al.
Oncogene (2024) Vol. 43, Iss. 11, pp. 763-775
Closed Access | Times Cited: 5
Epigenetic Regulation of Stromal and Immune Cells and Therapeutic Targets in the Tumor Microenvironment
Kang Liu, Yue Li, Minmin Shen, et al.
Biomolecules (2025) Vol. 15, Iss. 1, pp. 71-71
Open Access
Kang Liu, Yue Li, Minmin Shen, et al.
Biomolecules (2025) Vol. 15, Iss. 1, pp. 71-71
Open Access
Enhancer zeste homolog 2 (EZH2) targeting by small interfering RNA (siRNA); recent advances and prospect
Chou‐Yi Hsu, Ahmed Mohammed, Ahmed Hjazi, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Chou‐Yi Hsu, Ahmed Mohammed, Ahmed Hjazi, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Targeting EZH2 in autoimmune diseases: unraveling epigenetic regulation and therapeutic potential
Hassan Harirah, Mohammed H. Mohammed, M. S. Saleem Basha, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Hassan Harirah, Mohammed H. Mohammed, M. S. Saleem Basha, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Cellular senescence-related genes: predicting prognosis in hepatocellular carcinoma
Weiwei Yuan, Yuanmin Xu, Zhiheng Wu, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Weiwei Yuan, Yuanmin Xu, Zhiheng Wu, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Targeting polycomb repressor complex 2‐mediated bivalent promoter epigenetic silencing of secreted frizzled‐related protein 1 inhibits cholangiocarcinoma progression
Guanhua Wu, Qi Wang, Da Wang, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 12
Open Access | Times Cited: 4
Guanhua Wu, Qi Wang, Da Wang, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 12
Open Access | Times Cited: 4
Lysine methylation modifications in tumor immunomodulation and immunotherapy: regulatory mechanisms and perspectives
Yiming Luo, Junli Lu, Zhen Lei, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Yiming Luo, Junli Lu, Zhen Lei, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 1
ISG15 promotes tumor progression via IL6/JAK2/STAT3 signaling pathway in ccRCC
Wei Xie, Yuanfeng Zhang, Zhechuan Zhang, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access
Wei Xie, Yuanfeng Zhang, Zhechuan Zhang, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access
The role of miRNAs in the extracellular vesicle-mediated interplay between breast tumor cells and cancer-associated fibroblasts
Chen Li, Chao Yang, Qifeng Yang
Journal of Cancer Metastasis and Treatment (2024)
Open Access
Chen Li, Chao Yang, Qifeng Yang
Journal of Cancer Metastasis and Treatment (2024)
Open Access
The Heightened Importance of EZH2 in Cancer Immunotherapy
Lin Xiaohu, Wenkai Zhou, Chengzhong Lin, et al.
Cancer Screening and Prevention (2023) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 1
Lin Xiaohu, Wenkai Zhou, Chengzhong Lin, et al.
Cancer Screening and Prevention (2023) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 1
Cellular Senescence-Related Genes: Predicting Prognosis in hepatocellular carcinoma
Weiwei Yuan, Yuanmin Xu, Zhiheng Wu, et al.
Research Square (Research Square) (2023)
Open Access
Weiwei Yuan, Yuanmin Xu, Zhiheng Wu, et al.
Research Square (Research Square) (2023)
Open Access
